June 13, 2013  |  Adjournment

GlaxoSmithKline: job losses

I raise a matter for the Minister for Technology, Mr Gordon Rich-Phillips. In February last year the minister was promoting a $60 million investment by the pharmaceutical company GlaxoSmithKline (GSK) to expand its Boronia site in Melbourne’s outer eastern suburbs. Before I quote from his accompanying press release, I note that it is entitled ‘GSK injects $60 million and 58 jobs at Boronia site’, and it says: 

The Victorian coalition government is investing in the life sciences sector to ensure that the right conditions exist in Victoria to support the growth of life sciences companies, such as GSK. 
We recently released Victoria’s technology plan for the future — biotechnology — a $55 million plan to promote biotechnology-enabled innovation and support the growth of Victoria’s life sciences sector.

The minister refused to answer the question I am about to ask at a Public Accounts and Estimates Committee hearing in May. The action I seek from the minister is that he outline how much funding the government had originally planned to hand over to GlaxoSmithKline as part of this deal, whether he can guarantee that no money was actually handed over to the company, and if there was a deal, whether the funding was linked to job-security clauses. In addition, can he explain why this company has decided to offshore its operations if in fact it had a deal with the government?